Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk

Clinical trial NCT03315143 · TERMINATED

Trial details

NCT number

NCT03315143

Sponsor

Lexicon Pharmaceuticals

Status

TERMINATED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2017-12-19

Primary completion

2020-07-08

Enrollment

10584

View on ClinicalTrials.gov